Hosted on MSN7mon
FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung CancerAstraZeneca AZN announced that the FDA expanded the label of its blockbuster cancer drug Imfinzi for a fourth indication in lung cancer. The FDA approved Imfinzi in combination with platinum-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback